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Abstract
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne Alphavirus that causes a clinical disease involving fever,
myalgia, nausea and rash. The distinguishing feature of CHIKV infection is the severe debilitating poly-arthralgia that may
persist for several months after viral clearance. Since its re-emergence in 2004, CHIKV has spread from the Indian Ocean
region to new locations including metropolitan Europe, Japan, and even the United States. The risk of importing CHIKV to
new areas of the world is increasing due to high levels of viremia in infected individuals as well as the recent adaptation of
the virus to the mosquito species Aedes albopictus. CHIKV re-emergence is also associated with new clinical complications
including severe morbidity and, for the first time, mortality. In this study, we characterized disease progression and host
immune responses in adult and aged Rhesus macaques infected with either the recent CHIKV outbreak strain La Reunion
(LR) or the West African strain 37997. Our results indicate that following intravenous infection and regardless of the virus
used, Rhesus macaques become viremic between days 1–5 post infection. While adult animals are able to control viral
infection, aged animals show persistent virus in the spleen. Virus-specific T cell responses in the aged animals were reduced
compared to adult animals and the B cell responses were also delayed and reduced in aged animals. Interestingly,
regardless of age, T cell and antibody responses were more robust in animals infected with LR compared to 37997 CHIKV
strain. Taken together these data suggest that the reduced immune responses in the aged animals promotes long-term
virus persistence in CHIKV-LR infected Rhesus monkeys.
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Introduction
Chikungunya virus (CHIKV) is a re-emerging member of the
Alphavirus genus within the Togaviridae family. CHIKV was first
isolated in the 1950’s from the serum of a febrile patient in
Tanzania during a dengue fever-like outbreak [1]. The virus and
the associated disease were named chikungunya, meaning ‘‘that
which bends up’’ in the local language in reference to the debili-
tating poly-arthralgia that accompanies the infection [2]. Minor
outbreaks of CHIKV continued to occur until 2004 when a large
epidemic in Kenya marked the beginning of a 4-year period in
which CHIKV was imported into several new countries [3,4].
Several outbreaks occurred in India, where over one million cases
were reported [5,6]. In 2006, over 200,000 cases were reported on
the island of La Reunion [7,8], the most significant aspect of that
outbreak being that a single point mutation in the viral envelope
glycoprotein allowed the virus to replicate to very high titers in
both Aedes (Ae.) albopictus and Ae. aegypti mosquitos, which are widely
distributed throughout the world [3,9,10]. Viremic travelers return-
ing from India initiated a local outbreak in Italy through infection
of Ae. albopictus mosquitoes [11,12]. CHIKV cases from travelers
returning from endemic regions were also reported in France and
the United States, demonstrating the potential of CHIKV spread to
distant locales [13,14].
Clinical symptoms of CHIKV infection in humans include acute
fever lasting up to two weeks and severe poly-arthralgia of the peri-
pheral joints that can be very debilitating and last for several months.
Additional symptoms include nausea, headache, rash and lymph-
adenopathy. Although CHIKV infection is usually a self-limiting
disease, the outbreaks occurring after 2005 were explosive and
exhibited complicated clinical-pathological manifestations includ-
ing neurological involvement. Aged individuals and adults with
underlying immunological conditions experienced severe morbi-
dity and sometimes mortality [15] indicating that a functional
PLOS Neglected Tropical Diseases | www.plosntds.org 1 July 2013 | Volume 7 | Issue 7 | e2343
immune system maybe important to control infection and promote
recovery. Recent epidemics also showed the first CHIKV intra-
partum maternal–fetal transmission with devastating outcomes [16].
In addition, age-matched studies during an outbreak in Singapore
found that women are more susceptible to CHIKV-induced chro-
nic arthralgia than men [17,18]. Treatment of CHIKV infection
and disease is currently limited to supportive care. Therefore, the
development of effective CHIKV vaccines and therapeutics are
currently being intensely explored.
The immune response to CHIKV infection has been relatively
understudied. A limited number of studies characterized changes
in plasma cytokine/chemokine levels following CHIKV infection
in order to identify predictors of poor disease prognosis. These
analyses revealed that the acute phase of infection (4 days post
onset of illness) is associated with the production of robust Type-1
interferon (IFN) [17,19]. The level of IFN directly correlated with
viral load [20]. The chemokines IP-10 (CXCL10), MCP-1 (CCL2)
and RANTES as well as the cytokines IL-6, IL-1b IL-1Ra and IL-
12 are similarly expressed early following infection and their levels
correlate with viral loads [21]. Similar findings have been observed
in CHIKV-infected non-human primates [22]. High viral loads
during the early viral convalescence phase have also been associated
with increased IL-12 and IL-6 levels compared to patients with
lower viral loads [17]. Interestingly, increased IL-6 and GM-CSF are
observed in patients experiencing chronic joint pain (2–3 months
post onset of disease) whereas, increases in Eotaxin and hepatocyte
growth factors are associated with a full recovery from CHIKV
disease [17]. The functional relationship between expression of these
two proteins and disease recovery warrants further investigation.
The adaptive immune responses to CHIKV infection have not
been as widely investigated. In one study, the acute phase of CHIKV
infection in a human cohort from a 2007 CHIKV outbreak in
Gabon was found to be associated with CD8+ T cell activation.
However, the antiviral specificity of the CD8 T cell response and its
contribution to disease resolution were not investigated [19].
CHIKV-associated antibody responses have been better charac-
terized. CHIKV infection induces robust neutralizing antibody
responses in both humans and animal models. In fact, neutralizing
antibodies directed against E2 have been found to be protective and
the early presence of IgG3 antibodies have been correlated with
protection from persistent arthritis in patients from a 2008 CHIKV
outbreak in Singapore [23,24]. Unfortunately, we have a limited
knowledge as to the viral protein(s) are targeted or by what specific
immune cell subsets, nor do we know the timing of these events.
Here, we describe the infection of adult and aged Rhesus macaques
with either the Senegal strain (CHIKV-37997) or the reemergent
strain (CHIKV-LROpy-1). We detail the innate and adaptive immune
antiviral responses following infection. Rhesus macaques infected
with CHIKV become viremic within 24 hours of inoculation and
this was typically resolved by 5 days post-infection (dpi). All animals
generated robust T and B cell responses that peaked by 14 dpi.
However, our study demonstrates that aged animals persistent viral
RNA in the spleen. Interestingly, this inability to clear the virus in
the aged animals correlated with reduced innate and adaptive
immune responses compared to adult animals. Our findings suggest
that defects in the aged immune system play a critical role promo-
ting CHIKV persistence.
Materials and Methods
Ethics statement
All Rhesus macaques were handled in accordance with good
animal practice as defined by relevant national and/or local animal
welfare bodies. The use of non-human primates was approved by
the Oregon National Primate Research Center (ONPRC) Institu-
tional Animal Care and Use Committee (IACUC #0826). The
ONPRC is fully accredited by the Assessment and Accrediatation
of Laboratory Animal Care-International. For blood collection
monkeys were anesthetized with ketamine by intramuscular injec-
tion. Monkeys were humanely euthanized by the veterinary staff at
ONPRC in accordance with endpoint policies. Euthanasia was
conducted under anesthesia with ketamine followed by overdose
with sodium pentobarbital. This method is consistent with the
recommendation of the American Veterinary Medical Association.
Viruses
The full-length infectious clones for the West African (Senegal)
strain CHIKV-39779 and the recent outbreak strain La Re´union
(LR2006 OPY1; CHIKV-LR) were obtained from Dr. Stephen
Higgs University of Texas Medical Branch-Galveston. The viruses
produced from the infectious clones retain their original viral
phenotypes of CHIKV in both cell culture and in mosquitoes.
RNA was transcribed using the T7 mMessage mMachine kit
(Ambion). The transcribed RNA was transfected into BHK cells
and the resultant virus was propagated in C6/36-insect cells to
produce low passage, high titer CHIKV stocks by pelleting through
a 20% sucrose cushion by ultracentrifugation (22,000 rpm, 825206g
for 1.5 hrs). Plaque titration assays on Vero cells using a carboxy-
methylcellulose overlay were performed to determine titers (plaque
forming units) of the stock virus.
RNA transcribed from the infectious clones of CHIKV-LR and
CHIKV-37997 was transfected into BHK cells and passaged one
time in insect cells to generate the virus stock used to infect the animals.
Animal infection and sample collection
Adult male and female rhesus macaques (ranging from 6–13
years old) and aged female rhesus macaques (.17 years old) were
utilized for infection studies as described in Table 1. Animals were
infected intravenously with 16107, 16108 or 16109 plaque
forming units (pfu) CHIKV-LR or CHIKV-37997 strain in 1 ml
of phosphate buffered saline (PBS), and a sample of all viral
inoculums was back-titered to confirm the delivery of correct
dosage. Blood samples were obtained following ketamine sedation
(10 mg/Kg) at 4 and 2 weeks prior to infection, on the day of
infection (day 0), 1, 2, 3, 5, 7, 10 and14 days post infection and on
Author Summary
Chikungunya virus (CHIKV) is a re-emerging Alphavirus
that has caused recent massive outbreaks in the Indian
Ocean region. In addition, outbreaks have been docu-
mented in Europe and elsewhere in the world, initiated by
infected travelers returning to their homelands. The recent
outbreak strains possess extended vector range and as
such, raise the potential of CHIKV outbreaks in the
Southeastern parts of the United States. In this study, we
examined CHIKV immunity in adult and aged Rhesus
macaques following infection with two different CHIKV
strains (recent outbreak strain CHIKV-LR and a West African
Strain CHIKV-37997). CHIKV-LR causes persistent infection
in the aged animals and replicates, on average, to higher
levels than CHIKV-37997. Irrespective of the viral strain
used, aged animals had delayed and/or reduced immunity
compared to adult animals. Our data support the clinical
findings of CHIKV susceptibility in vulnerable populations
including the aged and provide mechanistic evidence that
an effective immune response directed against the virus is
required for preventing persistent CHIKV infection.
Aged Animals Have Reduced Immunity to CHIKV
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a weekly basis thereafter. Complete blood cell counts were
obtained at every time point to monitor changes in immune cell
numbers/ml of blood. Peripheral blood mononuclear cells (PBMC)
were isolated from whole blood by centrifugation over Histopaque
gradient (Histopaque, Sigma-Aldrich, St Louis, MO).
Quantitative RT-PCR analysis for CHIKV
Viral load in peripheral blood (plasma and PBMC) as well as
tissues at necropsy of the rhesus macaques was quantified using
real-time RT-PCR. Primers and probes include: CHIKV-LR fwd:
GGAACGAGCAGCAACCTTTG, rev: ATGGTAAGAGTCT-
CAGACAGTTGCA, and probe: GGAATAAGGGCTTGT;
CHIKV-37997 fwd: CGGAGAGCCGTAAGCTTCTTAA, rev:
TTCACACGAAACCACTGTATCACA, and probe: CTTCAG-
TGTTCCATCTAAA. Total RNA was prepared from 100 ml of
animal sera using the ZR Viral RNA kit (Zymo Research, Irvine,
CA) or from 56106 total PBMC using Trizol. RNA was prepared
from tissue specimens by the Trizol method. The isolated RNA
was quantified using a Nanodrop spectrophotometer. RNA was
first treated with RNAse-free DNAse and then single stranded
cDNA was generated using random hexamers and Superscript III
RT (Invitrogen, Carlsbad, CA). Gene amplicons served as quanti-
fication standards (limit of detection is 10–100 copies). Quantiative
RT-PCR results were analyzed using ABI StepOne Plus Real-
Time PCR system (Applied Biosystems, Foster City, CA).
CHIKV overlapping peptide library
CHIKV peptides were designed to be 18 mers that overlapped
by 12 amino acids covering the entire CHIKV proteome (peptides
were purchased from Thermo Fischer Scientific). Peptides were
resuspended in DMSO at 1 mg/ml. Separate peptides pools were
made for each of the nine viral protein products.
Measuring CHIKV-specific T cell responses
PBMC were stained with surface antibodies against CD4, CD8b,
CD28, and CD95 to delineate naı¨ve, central memory (CM), and
effector memory (EM) T cell subsets. All antibodies with the excep-
tion of CD8b (Beckman Coulter) were purchased from Biolegend
(San Diego, CA). Cells were then fixed and the nuclear membrane
permeabilized as per manufacturer’s recommendation (BD Phar-
mingen, San Diego, CA) before staining with anti-Ki67 (BD Phar-
mingen, San Diego, CA). Samples were acquired using the LSRII
instrument (BD bioscience, San Jose, CA) and data analyzed by
FlowJo (TreeStar, Ashland, OR).
Gamma interferon (IFN-c) enzyme linked immunospot (ELI-
SPOT) assays were performed using the ELISpotPlus for Monkey
IFN-c kit (MabTech). Plates were washed one time with 200 ml/
well of PBS and then blocked for 30 minutes in 200 ml/well of
RPMI containing 10% fetal calf serum (FCS) and penicillin, strep-
tomycin and glutamine (RPMI-10). Overlapping CHIKV peptide
pools (1 mg/well) for each of the nine CHIKV proteins were added
to wells containing 26105 rhesus monkey PBMC (n = 3). Positive
controls (1 ml of each phorbol 12-myristate 13-acetate (PMA;
200 mg/ml stock) and Ionomycin (7 mM stock)) and negative
controls (DMSO; 1 ml) were also performed for each monkey
PBMC sample. Plates were incubated for 18 hrs at 37uC. After
incubation the plates were washed thoroughly with PBS and then
incubated with a biotin-conjugated anti-IFN-c antibody (1 mg/ml
in PBS plus 0.5% FCS) for 2 hrs at room temperature. Plates were
washed five times with PBS and then incubated with Streptavidin-
ALP in PBS plus 0.5% FCS for 1 hour. Plates were washed five
times and then developed with filtered BCIP/NBT substrate
solution. Flushing the wells with water stopped color development.
The plates were air-dried and the number of spot forming cells was
determined by subtracting the mean number of spots counted in
negative controls wells (n = 3) from the spots counted in each well.
The magnitude of the response was determined as the sum of the
spots counted per 66105 PBMC.
Measuring CHIKV-specific B cell responses
PBMC were stained with surface antibodies directed against
CD20 (Beckman Coulter), IgD (Southern Biotech) and CD27 (Bio-
legend, San Diego, CA) to delineate naive, marginal zone-like and
memory B cells. The cells were then fixed and the nuclear membrane
permeabilized as per manufacturer’s recommendation before addi-
tion of Ki67 (BD Pharmingen, San Diego, CA) specific antibodies.
Samples were acquired using the LSRII instrument (BD bioscience,
San Jose, CA) and data analyzed by FlowJo (TreeStar, Ashland, OR).
Antiviral IgG levels were measured in circulating plasma using a
standard ELISA assay using plates coated with CHIKV lysate or
CHIKV particle preparations, which reacts with CHIKV Abs. In
these experiments, serial three-fold dilutions of plasma were incu-
bated in triplicates CHIKV lysate or virus-coated ELISA plates for
1 hr prior to washing, staining with detection reagents (HRP-anti-
IgG) and addition of chromogen substrate to allow for detection
and quantitation of bound antibody molecules. Log-log transfor-
mation of the linear portion of the curve was then performed, 0.1
OD units was the cut-off point to calculate end point titers. Each
plate contained a positive control sample to normalize ELISA
titers between assays, and a negative control sample to ensure
assay specificity.
Measuring CHIKV-specific myeloid cell responses in
peripheral blood
PBMC were stained with surface antibodies directed against
CD3, CD11c, CD14, CD20, CD123 and DR to delineate
plasmacytoid dendritic cells, myeloid dendritic cells, DR+ lineage
negative other DCs and monocyte/macrophages. Samples were
acquired using the LSRII instrument (BD Bioscience, San Jose,
CA) and data analyzed by FlowJo (TreeStar, Ashland, OR).
Table 1. Animal groupings.
ID Groups Sex Wt (kg) Age (Y)
CHIKV
Strain
Virus
Dosage
[36]
20374 1/A F 6.4 11 LR 16107
21384 1/A F 5.8 13 LR 16107
21551 1/B F 6.6 9 LR 16108
22477 1/B F 6.2 8 LR 16108
23643 1/C M 13.3 6 LR 16109
28525 1/C M 12.2 10 LR 16109
20969 1/aged F 7 18 LR 16109
22163 1/aged F 6.2 18 LR 16109
22855 2/A F 5.6 11 37997 16107
22865 2/A F 7.2 13 37997 16107
22910 2/B F 5.4 11 37997 16108
23465 2/B F 8.2 11 37997 16108
28524 2/C M 13.5 8 37997 16109
28520 2/C M 8.4 9 37997 16109
20841 2/aged F 6.2 17/325 37997 16109
20994 2/aged F 6.4 18 37997 16109
doi:10.1371/journal.pntd.0002343.t001
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Measuring bioactive IFN production in plasma
Blood plasma (100 ml) obtained from adult and aged CHIKV
infected Rhesus macaques (3 dpi) was UV inactivated (36 for
30 seconds at 600 mJ). Plasma was added to rhesus macaques
fibroblasts cultured in 24-well plates for 24 hr. Recombinant
universal Type-1 IFN (RND Systems; 0.1, 1, 10 units/ml) treated
cells were used as positive controls and untreated cells were used as
a negative control. Total RNA was isolated from the cells using the
Trizol method (Life Technologies). Quantitiative RT-PCR was
used to measure Interferon-stimulated gene (ISG) expression using
primers and probes specific for Mx-1 and ISG-56. cDNA was
generated using Superscript III (Life Technologies) and analyzed
on an ABI StepOne Real-Time PCR system and normalized to
L32. Gene amplicons served as quantification standards (limit of
detection #100 copies/gene). ISG expression levels for each
sample were expressed as fold-change by comparison to untreated
cells. Data were analyzed by Prism Graph Pad software.
Statistical analysis
Data were analyzed using Prism Graph Pad software using
Two-way ANOVA, no post-test corrections were carried out due
to the small sample size.
Results
CHIKV infection results in higher and protracted viral
loads in aged animals
Recent outbreak strains of Chikungunya virus contain an adap-
tive mutation in the E1-protein that facilitates transmission via Ae.
albopictus (Asian Tiger) mosquitoes as well as increased virulence.
We sought to compare CHIKV-LR virus disease progression and
host immune responses infection with that of a West African
reference strain (37997) to determine whether CHIKV-LR was
also more pathogenic in non-human primates. We also explored
the impact of aging on virus replication and immune response to
both of these strains. We first performed a titration experiment to
determine the effects of virus strain and inoculation dosage on in
vivo CHIKV replication and pathogenesis. Two cohorts of adult
rhesus macaques were infected intravenously with either CHIKV-
LR or CHIKV-37997. Each cohort consisted of 3 groups of 2
animals each that received 16107, 16108 or 16109 plaque
forming units of either strain and animals were observed daily for
signs of disease. Animals developed lymphadenopathy 7–14 dpi as
well as fever between 3–7 dpi. A rash was observed on the chest of
some of the animals at 7 dpi (data not shown). We compared viral
Figure 1. CHIKV viremia in blood peaks 1 to 2 days post infection of Rhesus macaques. CHIKV load in plasma and PBMC was quantified by
qRT-PCR using virus specific primers and probes. A and C) Virus was detected in RNA prepared from 10 ml of plasma using ZR Viral RNA extraction kit
(Zymol). B and D) Virus was detected in 0.1 mg of total RNA prepared with Trizol from 16106 PBMC.
doi:10.1371/journal.pntd.0002343.g001
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loads in peripheral blood mononuclear cells (PBMC) and plasma
at 0, 1, 2, 3, 5, and 10 dpi using qRT-PCR (Figure 1). In each
cohort viral loads were detectable by 2 dpi and viremia was
resolved by 5 dpi. Interestingly, the inoculation dose had no detec-
table impact on peak viremia or on the kinetics of viral replication
(Figure 1). We therefore treated all animals infected with a given
strain as one cohort for the remainder of our analysis. While we
did not detect statistically significant differences in peak plasma
virus levels between CHIKV-LR and CHIKV-37997, average
viral loads were nearly 10-fold higher in CHIKV-LR infected
animals (5.76106 vs. 5.96105 RNA genomic copies per 10 ml of
plasma, respectively; p = 0.15). CHIKV RNA levels were very low
in PBMC but as described for plasma were slightly higher in
CHIKV-LR infected animals (4,650 vs. 878 RNA genomic copies
per 0.1 mg of total RNA; respectively, p = 0.29 (Figure 1B vs. 1D).
To investigate whether advanced age is associated with more
severe CHIK disease, we infected 4 aged animals (.17 years of
age) with 16109 pfu CHIKV-LR (n = 2) or CHIKV-37997 (n = 2).
We compared peak viral loads and the kinetics of viral replication
between the aged and adult cohorts (Figure 1). The kinetics of
viremia were comparable in both young and aged animals for both
virus strains. However, while no virus was detected after 5 dpi in
adult animals, one of the aged CHIKV-LR animals had detectable
persistent viral RNA in plasma at 10 dpi (Figure 1A; Animal
#20841). Levels of virus detected in the PBMC of the aged
CHIKV-LR infected animals tended to be higher compared to
adult animals or aged animals infected with CHIKV-37997
(Figure 1B &D).
All animals were euthanized at 35–42 dpi, at which point, blood,
spleen, lymph nodes and joint tissues were harvested to determine
viral loads. At the time of necropsy, we observed no gross joint
inflammation in any of the animals. In addition, we detected no
virus in tissues harvested from adult animals at 35 dpi. However,
viral RNA was present in spleen of aged CHIKV-LR infected
animals but not in aged animals infected with CHIKV-37997
(Figure 2). Interestingly, aged animal #20994 infected with
CHIKV-LR had both the highest levels of PBMC associated virus
and highest level of spleen-associated virus compared to all other
infected animals. These findings suggest that CHIKV-LR can
persist in aged animals and is potentially more virulent than 37997.
The higher PBMC viral loads in CHIKV-LR infected aged animals
as well as the persistence of viral RNA in the spleen could be due to
increased viral replication and/or an ineffective immune response.
T cell responses are reduced in aged animals following
CHIKV infection
Next, we investigated the impact of age on the adaptive immune
response to CHIKV. One of the hallmarks of the immune response
against a viral infection is rapid and robust proliferation of antigen
specific lymphocytes. We therefore compared the kinetics and
magnitude of the T cell proliferative burst in adult and aged
animals by determining the frequency of T cells expressing the
nuclear protein Ki67, which is induced during cell cycle [25].
Peripheral blood mononuclear cells isolated at different time points
after infection were first stained with antibodies directed against
CD4, CD8, CD28 and CD95 in order to delineate naı¨ve, central
(CM) and effector memory (EM) T cell populations as shown in
Figure 3A and previously described [25]. The cells were perme-
abilized, stained with antibodies directed against Ki67, and
analyzed by flow cytometry (FCM).
Figure 2. CHIKV-LR persists in spleen of aged Rhesus macaques. CHIKV load was quantified in spleen tissue at necropsy (35 dpi) by virus-
specific qRT-PCR from total RNA samples prepared using Trizol.
doi:10.1371/journal.pntd.0002343.g002
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Proliferation of CD4 CM cells was evident by 7 dpi in both
CHIKV-LR and CHIKV-37997-infected adult animals (Figure 3B
& C). The frequency of Ki67+ CD4 CM T cells peaked at 10 dpi
and remained elevated in CHIKV-LR infected animals until
14 dpi before returning to baseline at 28 dpi (Figure 3B). On the
other hand, after peaking at 10 dpi, the frequency of CD4 CM
Ki67+ T cells began to decrease in CHIKV-37997 infected
animals, returning to baseline at 21 dpi (Figure 3C). However, the
CD4 CM T cell proliferative burst was delayed in aged animals.
Specifically, CD4 CM proliferation was not initiated until 10 dpi
in aged CHIKV-LR infected animals and 14 dpi in aged CHIKV-
37997 animals (Figure 3B & C; p = 0.037 and p = 0.005, respec-
tively). Moreover, the CD4 CM proliferative burst was sustained
longer in aged animals infected with the LR strain compared to
37997. Overall, the frequency of proliferating CD4 CM T cells
was lower in aged animals compared to adults, and this difference
was most noticeable in CHIKV-37997 infected animals (Figure 3B
& C). CD4 EM T cell proliferation was detected 10 dpi and
peaked 14 dpi in LR infected young and aged animals before
returning to baseline at 21 dpi (Figure 3D). In 37997 infected adult
animals, CD4 EM T cell proliferation was detected and
peaked10 dpi returning to baseline by 21 dpi (Figure 3E). As
described for CD4 CM, CD4 EM T cell proliferation was delayed
in aged animals infected with CHIKV-37997 the peak occurring
14 dpi and returning to baseline levels 21 dpi (Figure 3E; p = 0.055).
In summary, proliferation of the CD4 CM subset preceded that of
the CD4 EM subset. In addition, CD4 T cell proliferative burst was
greater in animals infected with the LR strain compared to 37997
and aged animals infected with 37997 generated a smaller CD4 T
cell proliferative response than adult animals.
Similar patterns of proliferation were observed in the CD8 T
cell subsets. Proliferation within the CD8 CM subset was detected
in all LR-infected animals at 7 dpi (Figure 3F & G). Proliferation
peaked at 10 dpi and was sustained in both adult and aged animals
infected with the CHIKV-LR strain through 14 dpi, returning to
baseline by 21 dpi (Figure 3F). In contrast, CD8 CM proliferative
burst was shorter in adult animals infected with 37997 peaking
10 dpi and declining 14 dpi (Figure 3G). Aged animals infected
with 37997 exhibited a delayed and blunted CD8 CM prolifer-
ative response compared to adult animals (Figure 3G; p = 0.061).
Figure 3. Aged Rhesus macaques have lower T cell responses following CHIKV infection. T-cell proliferative burst was measured following
CHIKV infection. PBMC were stained with antibodies directed against CD4, CD8, CD28, CD95 and Ki67 (as shown in panel A). Fold increase in number
of Ki67+ cells was calculated for each time point. Cell populations were subdivided: B & C) CD4+ Central memory (CM) T-cells; D & E) CD4+ Effector
memory (EM) T-cells; F & G) CD8+ CM; H & I) CD8+ EM for animals infected with CHIKV-LR (panels B, D, F, H) or CHIKV-37997 (panels C, E, G, I). N = 6 for
adult and N= 2 for aged animals.
doi:10.1371/journal.pntd.0002343.g003
Figure 4. Magnitude and breadth of anti-CHIKV T cell responses is reduced in aged Rhesus macaques. IFN-c ELISPOT assays were used
to quantify anti-CHIKV T cell responses in peripheral blood lymphocytes at 35 dpi in adult and aged animals (n = 4). In triplicate wells, PBMC (26105)
were incubated overnight with overlapping peptides that corresponded to each of the 9 CHIKV proteins (NSP-1-4, Core, E1-3 and 6k). PMA/ionomycin
stimulation was used as a positive control and medium plus DMSO was used as a negative control. A) Representative wells from IFN-c ELISPOT assay
performed with PBMC from adult and aged animals. B) Average cumulative anti-CHIKV responses to all viral proteins were compared for adult vs.
aged Rhesus macaques (n = 4). C) Average response to individual CHIKV proteins (n = 4).
doi:10.1371/journal.pntd.0002343.g004
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Proliferation within the CD8 EM subset was detected 10 dpi,
remained stable until 14 dpi returning to baseline 21 dpi in
CHIKV LR-infected animals (Figure 3H). Adult and aged CHIKV-
LR infected animals generated comparable CD8 EM proliferative
bursts. CD8 EM in 37997-infected adult animals peaked 10 dpi
before returning to baseline 14 dpi. As described for all other
subsets, CD8 EM proliferation was delayed in 37997-infected aged
animals (p = 0.126). In summary, aged animals infected with
CHIKV-LR showed a comparable CD8 T cell proliferative burst
following viral infection compared to adult animals. In contrast, T
cell proliferation in aged animals infected with CHIKV-37997 was
delayed and blunted compared to that of adult animals.
To further characterize the impact of age on T cell response to
CHIKV infection in vivo, we used IFN-c ELISPOT assays to
determine the frequency of CHIKV-specific T cells in PBMC. A
complete overlapping peptide library to CHIKV was subdivided
into peptides for each of the 9 proteins (NSP-1-4, Core, E1-3 and
6k). PBMC collected at 35 dpi were incubated with peptides and
the mean numbers of spot forming units [26] per 66105 PBMC
were determined for four adult and four aged animals. A repre-
sentative example of the data is presented in Figure 4A and the
data summary is provided in Figure 4B. T cell response to CHIKV
antigens was quite broad targeting both structural and nonstruc-
tural proteins. The CHKV-specific T cell response in adult
Figure 5. Aged Rhesus macaques have a delayed and lower B cell proliferative response following CHIKV infection. Measurement of
B-cell proliferative burst following viral infection. PBMC were stained with antibodies directed against CD20, CD27, IgD and Ki67 (as shown in panel A)
and subdivided into (B & C) Marginal Zone (MZ)-like B cells and (D & E) memory B cells. Fold increase in number of Ki67+ B cells was calculated at each
time point. N = 6 for adult and N= 2 for aged animals.
doi:10.1371/journal.pntd.0002343.g005
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animals was higher compared to the aged animals (403688 vs.
256673, respectively; n = 4). Similarly, the breadth of the anti-
CHIKV T cell response to any given viral protein differed slightly
between adult and aged animals (Figure 4C). Frequencies of T
cells specific for NS1 dominate the T cell response in both adult and
aged animals, whereas the response to core protein was the second
largest in adult animals, NSP4 was the second largest target for aged
T cells. These data indicate that advanced age results in reduced
frequency and altered breadth of anti-CHIKV T cells response.
Aged animals generate reduced B cell responses
following CHIKV infection
We next assessed the B cell response by measuring the kinetics
and magnitude of the B cell proliferative response as well as IgG
production following infection. B cells can be subdivided into three
subsets based on the expression of CD27 and IgD as shown in
Figure 5A and previously described [25]: naı¨ve (Na, IgD+, CD272),
marginal zone like (MZ-like, IgD+, CD27+) and memory B cells
(IgD2, CD27+). MZ-like B cell proliferation in adult animals
infected with CHIKV-LR was detected at 10 dpi, peaked around
14 dpi and returned to baseline by 21 dpi (Figure 5B). MZ-like B
cell proliferation in aged animals was not detected until 14 dpi
(Figure 5B). Proliferation in the memory B cell subset was detected
at 14 dpi in adult and aged CHIKV-LR-infected animals (Figure 5D).
As described for T cell subsets, B cell proliferation was delayed and
reduced in CHIKV-37997-infected aged animals compared to
adult (Figure 5C & E). This difference was most noticeable for MZ-
like B cells (p = 0.074). Of note, memory B cell proliferation seemed
biphasic with detection of a second peak in adult animals infected
with both virus strains at 28 dpi that was absent in the aged
animals. This second proliferative peak could be indicative of MZ-
like B cells acquiring memory phenotype and continuing to pro-
liferate in adult animals. The lack of this second proliferative burst
in memory B cells in aged animals is likely another indication of the
failures of an aged immune system.
To further characterize B cell response, we measure IgG end
point titers by ELISA using 96-well plates coated with either
purified virus or cellular lysates produced from infected Vero cells.
When using purified virions as the antigen source, anti-CHIKV
IgGs were detected at 14 dpi and peaked near 21 dpi in LR-
infected adult animals (Figure 6A). The IgG response was
significantly reduced in aged animals (p,0.05 for days 21, 28
and 35). When using viral lysate as antigen, IgG titers were first
detected 14 dpi, continued to increase until 35 dpi and were
comparable between adult and aged animals (Figure 6B). Inter-
estingly, the peak IgG titers to viral lysate were 3-fold higher than
those to whole virions (end point titer of 14545 vs. 4881,
respectively). Similar kinetics were observed for the IgG response
Figure 6. Aged Rhesus macaques have reduced anti-virion antibody titers compared to adult animals following CHIKV infection.
The production of anti-CHIKV antibodies in aged Rhesus macaques was compared to adult animals. CHIKV-specific endpoint IgG titers were
measured using standard ELISA detecting either CHIKV purified virions (A & C) or CHIKV infected cell lysates (B & D) as the antigenic source. N= 6 for
adult and N= 2 for aged animals. Aged animals have lower antibody titers to whole virions compared to adult animals, whereas the production of IgG
responses to antigen present in CHIKV-infected cellular lysates were not age dependent.
doi:10.1371/journal.pntd.0002343.g006
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to CHIKV-37997 in adult animals (Figure 6C & D). The IgG
titers were also higher in response to lysate antigen compared to
virions (4-fold) (Figure 6C & D). However, in CHIKV-37997-
infected aged animals, peak IgG titers to virions or lysate were com-
parable between aged and adult animals (Figure 6C & D). These
data taken together indicate that IgG response against viral deter-
minants is reduced in LR-infected aged animals, possibly contrib-
uting to viral persistence in these animals. Further experimentation
will be required to determine whether there are differences in
specific antibody binding epitopes or avidity of antibodies that bind
CHIKV between the aged and adult RM [23,24].
Alteration of monocyte and dendritic cell populations
following CHIKV infection is age-dependent
Given the proposed role for monocyte/macrophages in
CHIKV pathogenesis [27] and formation of CHIKV immune
response, we characterized the effects of CHIKV infection on
myeloid cell populations in peripheral blood. For this assay, total
PBMC were stained with antibody panels allowing separation of
myeloid cells into 4 subpopulations: plasmacytoid dendritic cells
(pDC: CD32, CD11c2, CD142, CD202, CD123+ and DR+);
myeloid dendritic cells (mDC: CD32, CD11c+, CD142, CD202,
CD1232 and DR+); non-plasmacytoid/non-myeloid dendritic cells
(other DC: CD32, CD11c2, CD142, CD202, CD1232 and
DR+); and monocyte/macrophages (CD32, CD11c2, CD14+,
CD202, CD1232 and DR+) as depicted in Figure 7A. The
frequency of all DC subsets as well as monocyte/macrophages,
increased in the peripheral blood of adult animals after CHIKV
infection (Figure 7B–E). Of note, frequency of pDCs increased
,14 dpi only in adult animals (Figure 7B; p = 0.017 and p = 0.164
for LR vs. 37997 at 14 dpi respectively). This overall increase
appeared more dramatic following infection with 37997 compared
to LR strain. Frequency of mDCs increased in LR infected adult
and aged animals 14 dpi before returning to baseline (Figure 7C). In
37997 infected adult animals, mDC frequencies increased 7 dpi and
remained fairly stable whereas aged animals did not experience any
changes in mDC numbers. Frequency of other DC increased
following infection with CHIKV-LR strain reaching comparable
peak levels 7 dpi in both adult and aged animals before returning
slowly to baseline levels 42 dpi (Figure 7D). In contrast, infection
with 37997 induced an increase in the frequency of other DCs only
in adult animals (p = 0.029). Lastly, frequencies of monocyte/
macrophages increased only in adult animals infected with both
CHIKV strains (Figure 7E; LR p = 0.019 and 37997 p = 0.048). As
described for pDCs and other DCs, this increase was more dramatic
following 37997 than LR infection.
To determine whether the innate immune response was also
affected by age following CHIKV infection, we measured plasma
levels of bioactive IFN. For this experiment, rhesus macaque fibro-
blasts were treated with UV inactivated plasma from CHIKV
infected aged or adult animals at 3 dpi. Interferon stimulated gene
(ISG) expression was determined by quantitative RT-PCR using
specific primers. We detected a trend towards increased ISG expres-
sion in fibroblasts treated with plasma from the adult animals indi-
cating that the levels of bioactive IFN was higher in those samples
but this difference did not reach statistical significance (Figure 8).
Discussion
Chikungunya virus is a re-emerging Alphavirus that causes
debilitating arthralgia. The 2006 outbreak on the island of La
Reunion involved a newly emerged CHIKV strain. This strain
exhibits both an increased vector range making more widespread
Figure 7. Macrophage and dendritic cell population changes following CHIKV infection observed in adult animals are reduced in
aged Rhesus macaques. Measurement of dendritic cell and monocyte/macrophage populations following CHIKV infection. PBMC were stained
with antibodies directed against CD3, CD11c, CD14, CD20, CD123 and HLA-DR (shown in panel A) and subdivided into plasmacytoid DCs (B); myeloid
DCs (C); non-P/non-M DC’s (D); monocyte/macrophages (E). Fold increase in numbers of cells was calculated. N = 6 for adult and N= 2 for aged
animals.
doi:10.1371/journal.pntd.0002343.g007
Figure 8. Plasma from aged Rhesus macaques have lower levels of bioactive IFN compared to adult animals. Plasma samples from
adult (Animal#22855, 21551, 20374) and aged (Animal#20969, 22163, 20994) RM at 3 days post infection with CHIKV were serially diluted and used
to stimulate Rhesus fibroblasts for 24 hours. Recombinant universal Type-1 IFN stimulated cells (0.1, 1, 10 units/ml) were used as positive controls and
untreated cells were used as a negative control. Then total RNA was prepared with Trizol and IFN stimulated genes Mx1 (A) and ISG56 (B) were
quantified by qRT-PCR using gene-specific primers. Fold change is determined as the ratio of gene expression treated vs. untreated control samples.
doi:10.1371/journal.pntd.0002343.g008
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transmission highly likely but also more severe virus-induced
disease. Ultimately these phenomena demonstrate that CHIKV is
an adaptable pathogen capable of rapidly expanding its ecological
niche and potentially emerging globally. Moreover, this new strain
was associated with increased mortality in the elderly and
newborns. Unfortunately, the host response to CHIKV infection
and associated determinants of disease remain poorly understood.
Characterization of the immune response following CHIKV
infection in humans is hampered by the occurrence of symptoms
at least a week after infection as well as severity of disease that can
differ dramatically between patients, which both influence the time
of presentation in the clinic. Thus, novel models that recapitulate
human CHIKV disease are needed to facilitate the identification
of the immune correlates of protection against CHIKV infection,
and for evaluation of therapeutics and vaccines. Recently studies
in Cynomolgus monkeys have shown that infection of non-human
primates results in similar pathophysiology as that described for
humans with the involvement of several joints, but the host immune
responses were not evaluated [22]. Therefore, we compared the
immune response following infection with the recent outbreak strain
CHIKV-LR to the West African strain 37997 in adult and aged
rhesus macaques.
This is the first report describing the impact of age on CHIKV
disease and immune response in non-human primates. Our results
show that although viremia is detected within 24 hpi in both adult
and aged animals, LR infection resulted in slightly higher peak
viremia. Interestingly, at necropsy (35 dpi) we were able to detect
persistent viral RNA in spleens harvested from aged but not adult
animals infected with the LR strain suggesting that aged animals
were unable to fully clear viral infection. One possible explanation
for persistent viral RNA in aged animals is a reduced immune
response to CHIKV. Therefore, we characterized the innate and
adaptive immune responses following CHIKV infection. Follow-
ing infection with CHIKV-LR, adult and aged rhesus macaques
generated comparable T and B cell proliferative responses, similar
IgG antibodies to viral lysate but lower IgG antibodies to whole
virions. In contrast, aged animals infected with 37997 generated
weaker T cell and B cell proliferative responses (delayed and
reduced) compared to adult animals, but the IgG responses were
comparable. We also measured frequency of CHIKV-specific T
cells using an overlapping peptide library for the entire CHIKV
proteome. Overall CHIKV-specific T cell responses were lower in
aged animals and the immunogenicity profiles differed. Aged
animals also failed to exhibit an increase in the frequency of
myeloid innate immune cells. This failure could be mediated by a
defect in innate immune cell mobilization or proliferation. Lastly,
production of bioactive Type 1 IFN was lower in the plasma of the
aged animals at 3 dpi. Taken together, our findings suggest that
aged animals have impaired ability to mount an effective immune
response against CHIKV infection.
Aging results in a general decline in immune function, commonly
known as immune senescence, which contributes to the increased
susceptibility to pathogens and cancer. Defects associated with
immune senescence have been shown in both innate and adaptive
processes. In the current report we found a reduction in innate
immune responses in the aged animals infected with CHIKV
compared to adult animals. Importantly, these responses were
observed in animals infected with either the LR or 37997 strains. Of
note, aged animals do not exhibit an increase in the frequency of
pDC. Given that pDCs play a critical role in the antiviral response
through the production of Type 1 IFN [28], the results presented in
this manuscript suggest that pDCs and production of type 1 IFN
may contribute to the successful control of CHIKV viremia.
Previous studies have shown a decrease in circulating pDC numbers
with increasing age [29,30]. The data presented here suggest
additional defects in pDC mobilization. We observed a correspond-
ing reduction in the production of plasma levels of bioactive Type 1
IFN in aged animals. Both clinical data and rodent studies using
IFNaR-/- and STAT1-/- mice demonstrate a critical role for type I
IFN in CHIKV clearance [20,31]. Others have demonstrated an
age-related decrease in IFN response through STAT1, IRF1 and
IRF7 signaling following infection with West Nile Virus [32,33].
Other cell types of the innate immune response such as macro-
phages and myeloid DCs play an important role in antigen
presentation and the initiation of the adaptive immune response.
Age-related defects in macrophage and DC antigen presentation
and migration reduce their ability to prime naı¨ve T cell responses to
novel pathogens [34,35]. Aged animals infected with CHIKV did
not show an increase in monocyte/macrophage and mDCs
following CHIKV infection. This defect could in part explain the
reduced T cell proliferation observed in 37997 infected animals
In line with decreased magnitude of the T cell proliferative
burst, we found reduced frequency of CHIKV-specific T cells in
the aged animals by IFN-c ELISPOT. Interestingly, the immuno-
dominance profile also differed between adult and aged animals.
Similarly, we observed a decreased IgG antibody response to
whole virions. However, IgG titers measured using plates coated
with viral lysate were higher than those measured using purified
virions suggesting that some of the antibody response is directed
against viral antigens that are not included in the virion. Collec-
tively, these findings indicate that the aged immune system is
incapable of mounting a broad and effective adaptive immune
response to CHIKV.
In summary, we present data indicating that the recent outbreak
strain CHIKV-LR replicated, on average, to higher levels com-
pared to the CHIKV strain 37997. While we did not observe
CHIKV-associated joint inflammation or disease for either virus in
these animals at 35 dpi, we did identify the spleen as a potential
site of CHIKV persistence in aged animals. This effect was limited
to CHIKV-LR and did not occur in monkeys infected with
CHIKV-37997, which is in line with the increased severity of
CHIKV-LR disease. We have also identified a number of diffe-
rences in the ability of adult vs. aged animals to respond to
CHIKV infection, with a general decline in both the innate and
adaptive immune responses that could explain the increased
disease severity observed in older individuals.
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